» Articles » PMID: 27762336

Microfluidic Co-culture System for Cancer Migratory Analysis and Anti-metastatic Drugs Screening

Overview
Journal Sci Rep
Specialty Science
Date 2016 Oct 21
PMID 27762336
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Tumour metastasis is an important reason for cancer death, and cancer cell migration is an important step in the process of tumour metastasis. Studying cancer cell migration is of great significance. Here, we present a novel microfluidic co-culture system and establish mild, moderate and severe cancer models by using HMEpiC and MDA-MB-231 cells to study cancer cell migration and anti-cancer drug screening. Using this device, we achieved high cell viability (over 90%) and a stable analysis of the migration ability of cancer cells. We observed that the density of the cancer cells determined the probability of the occurrence of metastatic cells and that the induction of normal cells affected the metastatic velocity of each cancer cell. We verified that the increase in the migration ability of MDA-MB-231 cells co-cultured with HMEpiC cells was relative to the increased secretion of IL-6 and that this was verified by an IL-6 inhibitor assay. This co-culture also led to decreased CK-14 secretion and morphological changes in HMEpiC cells. Finally, significant inhibition of paclitaxel and tamoxifen on cancer migration was observed. Taken together, our microfluidic device could be a useful tool for the quantitation of the migratory capability and anti-metastatic drug screening.

Citing Articles

Studying breast cancer lung metastasis using a multi-compartment microfluidic device with a mimetic tumor-stroma interaction model.

Zarin B, Rafiee L, Abdollahi S, Vatani M, Hassani M, Sanati-Nezhad A Transl Oncol. 2025; 53:102303.

PMID: 39904278 PMC: 11847141. DOI: 10.1016/j.tranon.2025.102303.


Highlight: microfluidic devices for cancer metastasis studies.

Scemama A, Lunetto S, Biddle A In Vitro Model. 2025; 1(6):399-403.

PMID: 39872614 PMC: 11756437. DOI: 10.1007/s44164-022-00023-y.


Modeling of the brain-lung axis using organoids in traumatic brain injury: an updated review.

Kim J, Song K, Han S, Youn D, Jung H, Kim K Cell Biosci. 2024; 14(1):83.

PMID: 38909262 PMC: 11193205. DOI: 10.1186/s13578-024-01252-2.


The progressive trend of modeling and drug screening systems of breast cancer bone metastasis.

Kolahi Azar H, Gharibshahian M, Rostami M, Mansouri V, Sabouri L, Beheshtizadeh N J Biol Eng. 2024; 18(1):14.

PMID: 38317174 PMC: 10845631. DOI: 10.1186/s13036-024-00408-5.


Research of restricted migration evaluation of MDA-MB-231 cells in 2D and 3D co-culture models.

Du Z, Yang S, Gong Q, Lin Z, Xiao G, Mi S Exp Biol Med (Maywood). 2024; 248(23):2219-2226.

PMID: 38240216 PMC: 10903235. DOI: 10.1177/15353702231214269.


References
1.
Sung K, Yang N, Pehlke C, Keely P, Eliceiri K, Friedl A . Transition to invasion in breast cancer: a microfluidic in vitro model enables examination of spatial and temporal effects. Integr Biol (Camb). 2010; 3(4):439-50. PMC: 3094750. DOI: 10.1039/c0ib00063a. View

2.
Gao Y, Majumdar D, Jovanovic B, Shaifer C, Lin P, Zijlstra A . A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology. Biomed Microdevices. 2011; 13(3):539-48. PMC: 3085600. DOI: 10.1007/s10544-011-9523-9. View

3.
Chen Y, Gao D, Liu H, Lin S, Jiang Y . Drug cytotoxicity and signaling pathway analysis with three-dimensional tumor spheroids in a microwell-based microfluidic chip for drug screening. Anal Chim Acta. 2015; 898:85-92. DOI: 10.1016/j.aca.2015.10.006. View

4.
Whitesides G, Ostuni E, Takayama S, Jiang X, Ingber D . Soft lithography in biology and biochemistry. Annu Rev Biomed Eng. 2001; 3:335-73. DOI: 10.1146/annurev.bioeng.3.1.335. View

5.
Nguyen T, Yin T, Reyes D, Urban G . Microfluidic chip with integrated electrical cell-impedance sensing for monitoring single cancer cell migration in three-dimensional matrixes. Anal Chem. 2013; 85(22):11068-76. DOI: 10.1021/ac402761s. View